ZNF628 Activators
ZNF628 activators encompass a diverse group of chemical compounds, each uniquely influencing the biochemical pathways that underlie ZNF628's functional role as a transcription factor. Forskolin, which elevates cAMP levels, indirectly promotes ZNF628 activity by activating PKA, potentially enhancing the phosphorylation of transcription factors that co-operate with ZNF628 to regulate gene expression. On the other hand, Retinoic Acid, by binding to nuclear RARs, can modulate the expression of genes within ZNF628's regulatory network, thus indirectly enhancingits functional activity. PMA, through PKC activation, and Ionomycin, by increasing intracellular calcium, both potentiate signaling cascades that can influence ZNF628's activity by modifying the phosphorylation state of associated proteins and transcription factors. EGCG's inhibition of protein kinases, Sodium Butyrate and Trichostatin A's HDAC inhibitory effects, and 5-Azacytidine's DNA methylation impact all converge to relax chromatin and promote gene expression, potentially enhancing ZNF628's regulatory capacity.
Additionally, Oligomycin's impact on cellular energy status indirectly affects ZNF628 by modulating AMPK activity and co-activator availability, while Lithium Chloride's inhibition of GSK-3 may stabilize transcription factors that interact with ZNF628. Pioglitazone, as a PPARγ agonist, could alter the expression of co-regulated genes, further influencing ZNF628's activity. Lastly, Curcumin's modulation of NF-κB signaling may enhance the transcriptional functions of ZNF628 by impacting the inflammatory response pathways and gene regulation. These activators, through their targeted biochemical actions, collectively support the enhancement of ZNF628's role in gene regulation without directly increasing its expression or acting as direct agonists.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing cAMP levels within the cell. Elevated cAMP activates PKA, which can phosphorylate various transcription factors, potentially enhancing the transcriptional activity of ZNF628 by facilitating its binding to DNA and recruitment of co-activators. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid acts as a ligand for nuclear retinoic acid receptors (RARs) which regulate gene expression. Binding of retinoic acid to RARs can lead to the alteration of gene expression profiles, including the activation of genes downstream or within the same regulatory network as ZNF628, hence indirectly enhancing ZNF628's functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate a wide range of cellular targets. PKC activation can lead to subsequent activation of signaling cascades that may include transcription factors and co-regulators of ZNF628, thus enhancing its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, activating calcium-dependent signaling pathways that could potentially enhance the activity of ZNF628 by modulating calcium-sensitive transcription factors and co-regulators associated with ZNF628 function. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits several protein kinases, altering signaling pathways and potentially reducing negative regulation on transcription factors that work in concert with ZNF628, thereby enhancing ZNF628 activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a histone deacetylase (HDAC) inhibitor which leads to a more relaxed chromatin structure and can enhance gene expression. This could increase the expression of target genes of ZNF628, thereby enhancing its functional role as a transcription factor. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
TSA is another HDAC inhibitor that can lead to chromatin remodeling and enhanced transcription of genes, potentially increasing the expression of genes regulated by ZNF628, indirectly enhancing its activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is an inhibitor of DNA methyltransferases, leading to reduced methylation of DNA. Hypomethylated DNA can result in the upregulation of gene expression, including genes that ZNF628 regulates, thus enhancing ZNF628's regulatory functions. | ||||||
Oligomycin A | 579-13-5 | sc-201551 sc-201551A sc-201551B sc-201551C sc-201551D | 5 mg 25 mg 100 mg 500 mg 1 g | $179.00 $612.00 $1203.00 $5202.00 $9364.00 | 26 | |
Oligomycin inhibits ATP synthase, leading to changes in cellular ATP levels and energy status. This can trigger AMPK activation which, in turn, may influence transcriptional regulation and co-activator availability for ZNF628, enhancing its activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium is known to inhibit glycogen synthase kinase-3 (GSK-3). Inhibition of GSK-3 can lead to the stabilization and activation of transcription factors that may interact or co-regulate with ZNF628, thus potentially enhancing ZNF628's transcriptional activity. | ||||||